Anlotinib + Benmelstobart + HAIC in Unresectable HCC: A Phase II Study

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Anlotinib + Benmelstobart + HAIC in Unresectable HCC: A Phase II Study	Unresectable Hepatocellular Carcinoma	Recruiting	Phase 2	2026-09-08		NCT07806292

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	285

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Guangzhou	China	13

Clinical trials